Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD [Deadline: Letters of intent are due on 13 January 2025 and full applications are due on 13 February 2025.]
The Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD funding from the National Institutes of Health (NIH) supports research projects that apply existing or newly developed artificial intelligence (AI) and…